Oral EA - Search Results

1

Leptin-replacement therapy for lipodystrophy.

Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A. Oral EA, et al. N Engl J Med. 2002 Feb 21;346(8):570-8. doi: 10.1056/NEJMoa012437. N Engl J Med. 2002. PMID: 11856796 Free article. Clinical Trial.

2

Familial lipodystrophy associated with neurodegeneration and congenital cataracts.

Berger JR, Oral EA, Taylor SI. Berger JR, et al. Among authors: oral ea. Neurology. 2002 Jan 8;58(1):43-7. doi: 10.1212/wnl.58.1.43. Neurology. 2002. PMID: 11781404

3

Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy.

Bolan C, Oral EA, Gorden P, Taylor S, Leitman SF. Bolan C, et al. Among authors: oral ea. J Clin Endocrinol Metab. 2002 Jan;87(1):380-4. doi: 10.1210/jcem.87.1.8176. J Clin Endocrinol Metab. 2002. PMID: 11788680

4

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI. Petersen KF, et al. Among authors: oral ea. J Clin Invest. 2002 May;109(10):1345-50. doi: 10.1172/JCI15001. J Clin Invest. 2002. PMID: 12021250 Free PMC article.

5

Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.

Oral EA, Ruiz E, Andewelt A, Sebring N, Wagner AJ, Depaoli AM, Gorden P. Oral EA, et al. J Clin Endocrinol Metab. 2002 Jul;87(7):3110-7. doi: 10.1210/jcem.87.7.8591. J Clin Endocrinol Metab. 2002. PMID: 12107209 Clinical Trial.

6

Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.

Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, Garg A. Haque WA, et al. Among authors: oral ea. Diabetes Care. 2003 May;26(5):1350-5. doi: 10.2337/diacare.26.5.1350. Diabetes Care. 2003. PMID: 12716787

7

Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.

Simha V, Agarwal AK, Oral EA, Fryns JP, Garg A. Simha V, et al. Among authors: oral ea. J Clin Endocrinol Metab. 2003 Jun;88(6):2821-4. doi: 10.1210/jc.2002-021575. J Clin Endocrinol Metab. 2003. PMID: 12788894

8

Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.

Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A, White NH, Bindl L, Herbst K, Kennel K, Patel SB, Al-Gazali L, Garg A. Agarwal AK, et al. Among authors: oral ea. J Clin Endocrinol Metab. 2003 Oct;88(10):4840-7. doi: 10.1210/jc.2003-030855. J Clin Endocrinol Metab. 2003. PMID: 14557463

9

Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy.

Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, Premkumar A, Depaoli AM, Skarulis MC, Oral EA, Gorden P. Moran SA, et al. Among authors: oral ea. Metabolism. 2004 Apr;53(4):513-9. doi: 10.1016/j.metabol.2003.10.019. Metabolism. 2004. PMID: 15045701 Clinical Trial.

10

Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome.

Cochran E, Young JR, Sebring N, DePaoli A, Oral EA, Gorden P. Cochran E, et al. Among authors: oral ea. J Clin Endocrinol Metab. 2004 Apr;89(4):1548-54. doi: 10.1210/jc.2003-031952. J Clin Endocrinol Metab. 2004. PMID: 15070911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters